EurekaMag.com logo
+ Translate

Human fascioliasis in Egyptian children: successful treatment with triclabendazole


, : Human fascioliasis in Egyptian children: successful treatment with triclabendazole. Journal of Tropical Pediatrics 45(3): 135-138

During a 2-year period human fascioliasis was diagnosed in 40 Egyptian children. Diagnosis was based on some or all of the following criteria: fever, tender hepatomegaly and high eosinophilia (febrile eosinophilic syndrome), presence of Fasciola hepatica ova in stools, and/or serodiagnosis using the indirect haemagglutination test (IHAT). Eight of the 40 children had failed to respond to previous treatment with praziquantel.

(PDF same-day service: $19.90)

Accession: 003162843

PMID: 10401189

DOI: 10.1093/tropej/45.3.135

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Lopez Velez, R.; Dominguez Castellano, A.; Garron, C., 1999: Successful treatment of human fascioliasis with triclabendazole. The clinical features, laboratory data, results of diagnostic studies and 3-month follow-up of 6 patients with Fasciola hepatica infection who were treated with 2 single doses of 10 mg/kg triclabendazole administered 2 days apart, are discussed. T...

Caminal Montero, L.; Fernández Fernández, C.; de Quirós, J.F.; Parra, F., 1999: The treatment of human fascioliasis with triclabendazole. Revista Clinica Espanola 199(5): 333-335

Farag, H.F.; E.K.oby, T.A.; Salem, A.I.; E.H.da, M.A.; Amin, G.A., 1998: Triclabendazole in the treatment of established human fascioliasis. The tolerance and efficacy of triclabendazole CGP 23030 were assessed in 50 Egyptian patients in the chronic phase of fascioliasis (caused by Fasciola spp.). After clinical examination, investigation and ultrasonography of the liver and biliary sy...

Curtale, F., 2008: Treatment of human fascioliasis with triclabendazole: good news. Transactions of the Royal Society of Tropical Medicine and Hygiene 102(5): 508-508

E.M.rshedy, H.; Farghaly, A.; Sharaf, S.; Abou Basha, L.; Barakat, R., 1999: Triclabendazole in the treatment of human fascioliasis: a community-based study. The efficacy of triclabendazole in the treatment of chronic Fasciola infection was assessed in 134 asymptomatic cases in Egypt (87 females and 47 males; age range 2 to 60 years old). 68 individuals received a single dose of 10 mg/kg and 66 receive...

el-Morshedy, H.; Farghaly, A.; Sharaf, S.; Abou-Basha, L.; Barakat, R., 2000: Triclabendazole in the treatment of human fascioliasis: a community-based study. The efficacy of triclabendazole in the treatment of chronic Fasciola infection was assessed. A total of 134 asymptomatic cases of established Fasciola infection were treated: 68 individuals received a single dose of 10 mg/kg and 66 individuals rec...

Merino Alonso, J.; Amérigo García, M.J.; Alvarez Rubio, L.; Erdozaín Ruiz, I., 1998: Human fascioliasis with atypical severe presentation. Treatment with triclabendazole. Fascioliasis is a zoonosis mainly involving sheep but which occasionally may be found in man as an accidental host. It is acquired by the consumption of herbs (watercress, wild endive, and dandelion) contaminated with metacercarias. The adult phas...

Neau, D.; Laharie, D.; Lieferman, F.; Monlun, E.; Malvy, D.; Longy Boursier, M.; Conri, C.; Beylot, J.; L.B.as, M., 1997: Treatment of human fascioliasis with triclabendazole Open study in 22 patients. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 37: 379

Youssif, M.I.; Khalil, S.S.; Osman, M.M., 1996: Enzymatic activities in the neutrophils of acute human fascioliasis before and after treatment with triclabendazole. Fasciola hepatica is a parasite that causes destruction of the liver tissue particularly during the acute phase of infection. Since the liver is the central organ of metabolism and supplies the blood with lipoproteins, therefore changes in blood l...

Apt, W.; Aguilera, X.; Vega, F.; Miranda, C.; Zulantay, I.; Perez, C.; Gabor, M.; Apt, P., 1995: Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. Between November 1990 and March 1992, 24 asymptomatic individuals in Chile with chronic hepatic fascioliasis confirmed by the presence of Fasciola hepatica eggs in feces were treated with a single oral dose of triclabendazole (10 mg/kg of body wei...